To print: Select File and then Print from your browser's menu

Title: Atorvastatin Has No Clinical Effect on Gonadal or Adrenal Steroid Hormones

URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R
Retrieve&db=PubMed&dopt=Abstract&list_uids=14564085

J Atheroscler Thromb 2003;10:3:160-4. "Atorvastatin treatment does not affect gonadal and adrenal hormones in type 2 diabetes patients with mild to moderate hypercholesterolemia"
11/03/2003 10:25:00 AM
By Mary Beth Nierengarten

Atorvastatin therapy for hypercholesterolaemia has no clinical effect on gonadal or adrenal steroid hormones in patients with type 2 diabetes, reports a study from Italy. Atorvastatin, a second generation synthetic 3-hydroxy 3-mthylglutaryl-coenzyme-A reductase inhibitor, is used treat hypercholesterolaemia, a condition that must be aggressively treated in patients with type 2 diabetes. However, along with reducing intracellular cholesterol synthesis and serum cholesterol levels, atorvastatin may also negatively effect gonadal and adrenal steroidogenesis. SA Santini, MD and colleagues, Catholic University of Medicine, Rome conducted a study to assess the effect of atorvastatin on gonadal and adrenal hormones in a cohort of patients with type 2 diabetes. Therapeutic doses of atorvastatin (20 mg/day) were given to 24 patients with type 2 diabetes (16 males, 8 postmenopausal females) with mild (LDL-cholesterol of 150.1 ą 32.0 mg/dl) or moderate (LDL-cholesterol of 189.9 ą 32.9 mg/dl) hypercholesterolaemia. Patients were evaluated before and after 3 months of atorvastatin therapy. Measurements taken from all patients included lipids and serum cortisol, dehydroepiandrosterone sulphate (DHEA-S), androstendione, and sex hormone binding globulin (SHBG). Testosterone and free testosterone index were also measured in males. A significant decrease in total and LDL cholesterol was observed after atorvastatin therapy ([P < .05), with no significant changes in HDL-cholesterol. Significance was not found in any of the patients between steroid hormones measured before or after administration of atorvastatin. The authors conclude that atorvastatin does not clinically effect gonadal or adrenal steroid hormones in patients with type 2 diabetes.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R
Retrieve&db=PubMed&dopt=Abstract&list_uids=14564085

Copyright Š 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.